KRAS mutations identified in duodenal lavage fluid after secretin stimulation demonstrated a high diagnostic accuracy for detecting resectable pancreatic ductal adenocarcinoma (pdac). With an area Under the Curve (AUC) of 0.934, the method achieved a sensitivity of 83.1% at 100% specificity, significantly outperforming traditional serum biomarkers. This innovative approach enhances early detection, which is crucial for effective pdac management and increasing survival rates, underscoring the potential for less invasive diagnostic techniques.
Journal Article by Yachida S, Yoshinaga S (…) Matsumoto K et 26 al. in Ann Surg
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.